肝素和尿激酶等治疗有较好的疗效。
目的比较低分子量肝素和尿激酶对肾小球炎症反应的保护作用。
Objective To investigate the protective effects of low-molecular heparin and urokinase on glomerular inflammation.
目的：评价抗凝药物肝素和维生素K拮抗剂的临床应用及安全性。
OBJECTIVE:To evaluate clinical usage and safe ty of anticoagulant Heparin and vitamin K antagon.
目前应用于临床治疗的抗凝血药物主要是肝素和香豆素类，有诱发血小板症等副作用。
At present, anticoagulant medicine used for clinic treatment is mostly heparin and coumarin, which has some side-effects, such as causing platelet disease and so on.
这些研究比较了血液稀释剂普通肝素和安慰剂、低分子肝素和安慰剂或是两种肝素之间的作用比较。
The studies compared the blood-thinner unfractionated heparin to a placebo, or low-molecular-weight heparin with a placebo, or both types of heparin with each other.
他们建议：由于使用依诺肝素和阿司匹林对母亲和胎儿具有最小限度的风险，对于经历过三次甚至更多怀孕失败的妇女，上述任意一种形式的治疗都应该被考虑。
"In view of the minimal risks of enoxaparin and aspirin to the mother and fetus," they recommend that "either form of treatment should be considered in women after three or more pregnancy losses."
目的：本研究的目的是为了分析静脉输注脂肪和肝素对健康妇女循环雄激素水平的影响。
Objective: the objective of the study was to analyze the effects of iv lipid and heparin infusion on circulating androgen levels in healthy women.
研究者利用了肝素（一种多糖）和血液中的抗凝血酶III（一种多肽片断）之间的相互作用来控制凝固时间。
Researchers have used the interaction between a polysaccharide called heparin and a peptide fragment of a protein called antithrombin III, which is contained in the bloodstream to control clotting.
结论：局部应用尿激酶和肝素能够促进内皮细胞的早期修复，作用机制可能相似。
Conclusion: Local application of urokinase can promote the endothelial healing. The mechanism of urokinase may be similar to that of heparin.
目的观察丹奥和低分子肝素联合治疗进展性脑梗死的疗效及安全性。
ObjectiveTo observe the combined effect and safety of Sodium Ozagrel and Low Molecular Heparin in the treatment of progressive cerebral infraction.
方法：对比测定了30例肝素锂抗凝血浆和血清标本的28项生化检验指标。
Methods Opposite test 28 biochemical index of 30 anticoagulant blood plasma with heparin Lithium and blood serum.
采用枸橼酸钠和肝素两种抗凝剂，对79例正常人和36例病人的红细胞沉降率进行了测定。
Methods Erythrocyte sedimentation rate of 79 normal controls and 36 patients was determined with sodium citrate and heparin.
目的：观察低分子肝素钙治疗脑梗死的有效性和安全性。
Objective: To explore the safety and efficiency of low molecular heparin calcium treating cerebral infarction.
目的：研究、探讨血小板源生长因子和肝素对培养的人主动脉平滑肌细胞表型转变调节作用，及其对平滑肌细胞胶原蛋白合成的影响。
Objective: to investigate the effect of platelet derived growth factor (PDGF) and heparin on regulating the transformation of phenotype and collagen synthesis in aorta smooth muscle cell (SMC).
连接组织、连接流质和软骨中便含有二元多糖，包括肝素。
Connective tissues, joint fluid, and cartilage contain two-component polysaccharides, including heparin.
一个具有静脉窦血栓和部分肝素治疗的胎盘剥离临产妇的区域麻醉。
Case reports regional anesthesia for a parturient with venous sinus thrombosis and placental abruption undergoing fractional heparin therapy.
结果：丁咯地尔组疗效较好，奥扎格雷组和低分子肝素钙组次之。
Result: The effect of buflomedil group was better than ozagrel group and low molecular heparin calcium group.
方法采用肝素钠乳膏外涂治疗干性湿疹和神经性皮炎共120例。
Method The heparin sodium cream was applied topically in 120 patients with asteatotic eczema and neurodermatitis.
目的：探讨缬沙坦和低分子量肝素对高糖刺激大鼠系膜细胞增殖的影响。
Objective: To observe the effect of valsartan and low molecular weight heparin on the proliferation of glomeruli mesangial cells stimulated by high glucose.
结论肝素与VEGF联用，能促进EC在人工血管的增殖和贴附率。
Conclusions: Heparin can be employed with VEGF to promote the growth and proliferation of EC on vascular prostheses.
当这两种肝素相比较时，低分子肝素能够减少32%的深静脉血栓和53%注射部位的血肿形成。
When compared with each other, low-molecular-weight heparin was associated with a 32 percent reduced risk of deep vein thrombosis and a 53 percent lower rate of hematoma at the injection site.
目的探讨人工髋关节置换术（THR）后用低分子肝素预防下肢深静脉血栓（DVT）形成的疗效和安全性。
Objective To evaluate the efficacy and safety of low-molecular-weight heparin(LMWH) in preventing for deep-vein thrombosis (DVT) after total hip replace(THR).
目的探讨鱼精蛋白中和的局部肝素化在高危出血倾向患者血液透析中临床应用的有效性和安全性。
Objective To explore the safety and effectiveness of the application of regional heparinization with protamine reversal in dialysis patients at high risk of bleeding.
目的：评价低分子肝素钙联合大剂量纳洛酮治疗早期急性脑梗死的临床疗效和安全性。
AIM: To evaluate the therapeutic effect and safety of low molecular weight heparin calcium combined with naloxone on acute cerebral infraction in early stage.
目的：观察低分子肝素钙对2型糖尿病肾病的疗效和安全性。
Objective: To observe the safety and efficacy of low molecular weight heparin calcic in treatment of type2 diabetic nephropathy.
目的考察低分子肝素肺靶向微球缓释性、稳定性和靶向性。
AIM To test gelatin microspheres of low molecular weight heparin (LMWH-GMS) release behavior; lung target behavior and stability.
目的研究等离子体引发低密度聚乙烯（LDPE）表面肝素化以及肝素化LDPE表面抗凝血性和组织相容性。
Aim To study the LDPE surface heparinization with plasma initiation technique, and antithrombogenicity and tissue compatibility of heparinizing LDPE surface.
本文介绍了肝素涂抹人工材料在心血管领域的应用和进展。
The review introduces application and advance of heparin coated artificial material in cardiovascular field.
本文介绍了肝素涂抹人工材料在心血管领域的应用和进展。
The review introduces application and advance of heparin coated artificial material in cardiovascular field.
应用推荐